Impact of pre-treatment symptom burden, response to treatment, and laboratory parameters on survival in small cell lung cancer

被引：0
|
作者：
Mohan, A [1 ]
Pandey, SGPPSSSRM [1 ]
Pathak, AK [1 ]
Bhutani, M [1 ]
Guleria, R [1 ]
机构：
[1] All India Inst Med Sci, New Delhi, India
来源：
CHEST | 2005年 / 128卷 / 04期
关键词：
D O I：
10.1378/chest.128.4_MeetingAbstracts.335S-b
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：335S / 336S
页数：2
相关论文
共 50 条
  • [1] PRE-TREATMENT SYMPTOM PROFILES PREDICT SURVIVAL IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Chen, Mei-Ling
    Yu, Chih-Teng
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1014 - S1015
  • [2] IMPACT OF PRE-TREATMENT SERUM LACTATE DEHYDROGENASE ON SURVIVAL IN PATIENTS WITH SMALL CELL LUNG CANCER.
    Takhar, Harminder S.
    Sukumaran, Shawgi
    Ly, Marleesa
    Woodman, Richard
    Karapetis, Chris
    Koczwara, Bogda
    Kichenadasse, Ganessan
    Roy, Amitesh
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S634 - S634
  • [3] The impact of pre-treatment smoking status on survival after chemoradiotherapy for locally advanced non-small-cell lung cancer
    Wallace, Neil D.
    Alexander, Marliese
    Xie, Jing
    Ball, David
    Hegi-Johnson, Fiona
    Plumridge, Nikki
    Siva, Shankar
    Shaw, Mark
    Harden, Susan
    John, Tom
    Solomon, Ben
    Officer, Ann
    MacManus, Michael
    LUNG CANCER, 2024, 190
  • [4] Pre-treatment clinical laboratory tests indicative of metabolic status are associated with survival in patients with non-small cell lung cancer
    Zhang, Fanmao
    Meng, Qing H.
    Ye, Yuanqing
    Hildebrandt, Michelle A. T.
    Huang, Maosheng
    Wu, Xifeng
    CANCER RESEARCH, 2014, 74 (19)
  • [5] Impact of Pre-treatment Immunologic Parameters on the Outcomes of Early-Stage Non-Small Cell Lung Cancer (NSCLC)
    Adu-Quaye, M.
    Dube, S.
    Rathod, S.
    Dubey, A.
    Bashir, B. M.
    Lambert, P.
    Bucher, O.
    Kim, J.
    Leylek, A.
    Ahmed, N.
    Chowdhury, A. D.
    Koul, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E118 - E118
  • [6] Pre-treatment serum lactate dehydrogenase as a biomarker in small cell lung cancer
    Hsieh, Amy Hsin-Chieh
    Tahkar, Harminder
    Koczwara, Bogda
    Kichenadasse, Ganessan
    Beckmann, Kerri
    Karapetis, Christos
    Sukumaran, Shawgi
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (02) : E64 - E70
  • [7] Influence of pre-treatment nutrition and inflammation on immunotherapy response in non-small cell lung cancer
    Robinson, Lary A.
    Kim, Youngchul
    Buro, Acadia
    Hogue, Stephanie R.
    Bailey, Alexis
    DeNicola, Gina M.
    Pierce, Christine
    Umbarger, Mark
    Byrd, Doratha A.
    CANCER RESEARCH, 2024, 84 (06)
  • [8] Pre-treatment CT radiomics predicts survival in chemo-immunotherapy-treated small cell lung cancer
    Bae, J.
    Prasanna, P.
    Gadgeel, S. M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1253 - S1253
  • [9] Radiomic analysis of pre-treatment FDG PET prognosticates survival in non-small cell lung cancer
    Cung, Christine
    Wong, Wenchang
    Martin, Rowena
    Shon, Ivan Ho
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [10] The impact of pre-treatment plasma sex hormones on the immune checkpoint inhibitors response to metastatic non-small cell lung cancer.
    Zhang, Yumeng
    Darville, Lancia
    Hogue, Stephanie
    Hallanger-Johnson, Julie E.
    Kim, Youngchul
    Gray, Jhanelle Elaine
    Robinson, Lary A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345